Fenfluramine: Clinical Trials

4 trials of Fenfluramine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 2, Recruiting 2

Follow Fenfluramine: new trials by email Literature Review of Fenfluramine trials Research Report on Fenfluramine

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project
Fenfluramine treatment (Fintepla), Hypercapnia Challenge using the device (RespirAct) - Dravet Syndrome
Phase 4RecruitingThe University of Texas Health Science Center, Houston252026-04-272026-07-15
Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age
fenfluramine - Dravet Syndrome (DS), Children Under 2 Years
Phase 4RecruitingUniversity of Colorado, Denver52024-10-222026-05-15
Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes
Fenfluramine - Refractory Epilepsy, SYNGAP1 Encephalopathy
Phase 4CompletedHospital Ruber Internacional202022-10-202026-09-29
Fenfluramine and Cognition
Fenfluramine, Placebo - Cognitive Function
Phase 4CompletedUniversity of Oxford562021-04-122022-11-15

Conditions studied

Epilepsies, Myoclonic (3)  ·  Epilepsy (2)  ·  Brain Diseases (1)  ·  Chromosome 15q, tetrasomy (1)  ·  Drug Resistant Epilepsy (1)  ·  Epileptic Encephalopathy, Early Infantile, 4 (1)  ·  Genetic Diseases, Inborn (1)  ·  Nervous System Diseases (1)  ·  Sudden Unexpected Death in Epilepsy (1)

Sponsors

Hospital Ruber Internacional (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  University of Colorado, Denver (1)  ·  University of Oxford (1)

Countries

United States (2)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Antonio Gil-Nagel, MD, PHD (1)  ·  Catherine J Harmer, DPhil (1)  ·  Kelly Knupp, MD (1)  ·  Samden Lhatoo, MD, FRCP (1)

Results publications

PMID 39122687